Theratechnologies completes Phase III HIV-associated lipodystrophy ... - Pharmaceutical Business Review PDF Print

By Staff Writer The confirmatory Phase III trial is a 400-patient, multi-center, double-blind, randomized, placebo-controlled study conducted in 48 centers ...

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.